Belinda N Rivera-Lebron

Dr. Belinda N Rivera-Lebron


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
PDF file
BRBelinda N Rivera-Lebron
Belinda N Rivera-Lebron
MMMichael McDaniel
Michael McDaniel
KAKamran Ahrar
Kamran Ahrar
AAAbdulah Alrifai
Abdulah Alrifai
DDDavid M. Dudzinski
David M. Dudzinski
TCthe PERT Consortium
the PERT Consortium
Pulmonary embolism (PE) is a life-threatening condition and a leading cause of morbidity and mortality. There have been many advances in the field of PE in the last few years, requiring a careful assessment of their impact on patient care. However, variations in recommendations by different clinical guidelines, as well as lack of robust clinical trials, make clinical decisions challenging. The Pulmonary Embolism Response Team Consortium is an international association created to advance the diagnosis, treatment, and outcomes of patients with PE. In this consensus practice document, we provide a comprehensive review of the diagnosis, treatment, and follow-up of acute PE, including both clinical data and consensus opinion to provide guidance for clinicians caring for these patients.

1 January 2021 in Chest
Verified
Journal Article
Closed access
BRBelinda N Rivera-Lebron
Belinda N Rivera-Lebron
PRParth M. Rali
Parth M. Rali
VTVictor F. Tapson
Victor F. Tapson

13 July 2023 in Medical Image Analysis
Verified
Journal Article
Closed access
JPJiantao Pu
Jiantao Pu
NGNaciye Sinem Gezer
Naciye Sinem Gezer
SRShangsi Ren
Shangsi Ren
AAAylin Ozgen Alpaydin
Aylin Ozgen Alpaydin
EAEmre Ruhat Avci
Emre Ruhat Avci
JLJoseph K. Leader
Joseph K. Leader

27 July 2022 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
MPMateo Porres‐Aguilar
Mateo Porres‐Aguilar
RRRachel P. Rosovsky
Rachel P. Rosovsky
BRBelinda N Rivera-Lebron
Belinda N Rivera-Lebron
SKScott Kaatz
Scott Kaatz
DMDebabrata Mukherjee
Debabrata Mukherjee
CJCarlos Jerjes‐Sánchez
Carlos Jerjes‐Sánchez

19 November 2018 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
MPMateo Porres–Aguilar
Mateo Porres–Aguilar
JAJavier E. Anaya-Ayala
Javier E. Anaya-Ayala
GHGustavo A. Heresi
Gustavo A. Heresi
BRBelinda N Rivera-Lebron
Belinda N Rivera-Lebron
Pulmonary embolism represents the third most common cause of cardiovascular death in the United States. Reperfusion therapeutic strategies such as systemic thrombolysis, catheter directed therapies, surgical pulmonary embolectomy, and cardiopulmonary support devices are currently available for patients with high- and intermediate-high–risk pulmonary embolism. However, deciding on optimal therapy may be challenging. Pulmonary embolism response teams have been designed to facilitate multidisciplinary decision-making with the goal to improve quality of care for complex cases with pulmonary embolism. Herein, we discuss the current role and strategies on how to leverage the strengths from pulmonary embolism response teams, its possible worldwide adoption, and implementation to improve survival and change the paradigm in the care of a potentially deadly disease.

9 April 2021 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
MPMateo Porres-Aguilar
Mateo Porres-Aguilar
MHMarius Hoeper
Marius Hoeper
BRBelinda N Rivera-Lebron
Belinda N Rivera-Lebron
GHGustavo A. Heresi
Gustavo A. Heresi
DMDebabrata Mukherjee
Debabrata Mukherjee
VTVictor F. Tapson
Victor F. Tapson